Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 1Phase 2 1

Status

Recruiting 3Completed 3Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 12Breast 7Thoracic 5Gynecologic 5Tumor-Agnostic 2Other 2Head & Neck 2Plasma cell 1Genitourinary 1

Conditions

Breast Neoplasms 6Inflammation 1Diarrhea 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Probiotics × Breast × Clear all
NCT07607548 2026-05-26

Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer

Poznan University of Medical Sciences

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Inflammation

NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting
160 enrolled
Breast

Breast Neoplasms

NCT06039644 2026-03-06

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

GenMont Biotech Incorporation

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
308 enrolled
Breast

Breast Neoplasms, Diarrhea

NCT07044310 2025-07-29

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Mayo Clinic

Phase 2 Recruiting
38 enrolled
Breast

Breast Carcinoma In Situ

NCT03358511 2020-05-21

Engineering Gut Microbiome to Target Breast Cancer

Mayo Clinic

Phase NA Completed
7 enrolled
Breast

Breast Neoplasms

NCT01723592 2017-06-06

Orall Administered Probiotics to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.

Medical University of Vienna

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡